In the past week, SBRA stock has gone down by -0.81%, with a monthly gain of 5.86% and a quarterly surge of 5.13%. The volatility ratio for the week is 1.95%, and the volatility levels for the last 30 days are 2.04% for Sabra Healthcare REIT Inc. The simple moving average for the past 20 days is 1.89% for SBRA’s stock, with a 4.19% simple moving average for the past 200 days.
Is It Worth Investing in Sabra Healthcare REIT Inc (NASDAQ: SBRA) Right Now?
The price-to-earnings ratio for Sabra Healthcare REIT Inc (NASDAQ: SBRA) is above average at 31.21x, Company’s 36-month beta value is 0.82.Analysts have differing opinions on the stock, with 6 analysts rating it as a “buy,” 1 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for SBRA is 233.52M, and currently, short sellers hold a 8.35% ratio of that floaft. The average trading volume of SBRA on July 01, 2025 was 2.61M shares.
SBRA) stock’s latest price update
The stock of Sabra Healthcare REIT Inc (NASDAQ: SBRA) has increased by 0.99 when compared to last closing price of 18.26.Despite this, the company has seen a loss of -0.81% in its stock price over the last five trading days. seekingalpha.com reported 2025-06-28 that “One Big Beautiful Bill” inches closer to becoming law. It will have an impact on the broader economy, and especially certain specific sectors. Some dividend stocks could be in serious trouble, while others could gain. I share my take as a dividend investor.
Analysts’ Opinion of SBRA
JMP Securities, on the other hand, stated in their research note that they expect to see SBRA reach a price target of $20. The rating they have provided for SBRA stocks is “Mkt Outperform” according to the report published on January 07th, 2025.
Mizuho gave a rating of “Neutral” to SBRA, setting the target price at $20 in the report published on December 05th of the previous year.
SBRA Trading at 3.34% from the 50-Day Moving Average
After a stumble in the market that brought SBRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.76% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SBRA starting from FOSTER MICHAEL J, who sale 11,000 shares at the price of $18.22 back on May 20 ’25. After this action, FOSTER MICHAEL J now owns 64,725 shares of Sabra Healthcare REIT Inc, valued at $200,376 using the latest closing price.
Stock Fundamentals for SBRA
Current profitability levels for the company are sitting at:
- 0.52 for the present operating margin
- 0.72 for the gross margin
The net margin for Sabra Healthcare REIT Inc stands at 0.19. The total capital return value is set at 0.11. Equity return is now at value 5.15, with 2.65 for asset returns.
Based on Sabra Healthcare REIT Inc (SBRA), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 0.65. The interest coverage ratio of the stock is 4.29.
Currently, EBITDA for the company is 412.61 million with net debt to EBITDA at 4.15. When we switch over and look at the enterprise to sales, we see a ratio of 8.48. The receivables turnover for the company is 5.72for trailing twelve months and the total asset turnover is 0.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.25.
Conclusion
In a nutshell, Sabra Healthcare REIT Inc (SBRA) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
